The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Requirement for the Transcription Factor LSIRF/IRF4 for Mature B and T Lymphocyte Function
Abstract
Lymphocyte-specific interferon regulatory factor (LSIRF) (now called IRF4) is a transcription factor expressed only in lymphocytes. Mice deficient in IRF4 showed normal distribution of B and T lymphocyes at 4 to 5 weeks of age but developed progressive generalized lymphadenopathy. IRF4-deficient mice exhibited a profound reduction in serum immunoglobulin concentrations and did not mount detectable antibody responses. T lymphocyte function was also impaired in vivo; these mice could not generate cytotoxic or antitumor responses. Thus, IRF4 is essential for the function and homeostasis of both mature B and mature T lymphocytes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pip-deficient animals develop normal numbers of B cells (including λ-expressors) which cannot undergo activation”
From Assembly requirements of PU.1–Pip (IRF‐4) activator complexes: inhibiting function in vivo using fused dimers (1999) · cites this paper as Mittrucker et al., 1997
In the citing paper
“whereas PIP function is necessary for maturation of B and T lymphocytes (34”
From AKT Induces Transcriptional Activity of PU.1 through Phosphorylation-mediated Modifications within Its Transactivation Domain (2001) · cites this paper as [34]
In the citing paper
“whereas PIP−/− animals exhibit a block in peripheral maturation of B cells and fail to produce antibodies in response to antigenic stimulation.”
From AKT Induces Transcriptional Activity of PU.1 through Phosphorylation-mediated Modifications within Its Transactivation Domain (2001) · cites this paper as [34]
In the citing paper
“Similarly, T cells of the mutant animals (PIP−/−) lack proliferative and cytotoxic responses (34”
From AKT Induces Transcriptional Activity of PU.1 through Phosphorylation-mediated Modifications within Its Transactivation Domain (2001) · cites this paper as [34]
In the citing paper
“IRF-4 2 / 2 mice develop progressive generalized lymphadenopathy and have severe defects in B and T lymphocyte function. (65)”
From Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells (2002) · cites this paper as [65]
In the citing paper
“IRF-4 2 / 2 mice develop progressive generalized lymphadenopathy and have severe defects in B and T lymphocyte function. (65)”
From Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells (2002) · cites this paper as [65]
Citations
Cites
Differential T Cell Costimulatory Requirements in CD28-Deficient Mice
Shahinian, A., Pfeffer, K., Lee, K. P., Kündig, T. M., Kishihara, K., Wakeham, A. C., Kawai, K., Ohashi, P. S., Thompson, C. B., & Mak, T. W. (1993) · Science · doi:10.1126/science.7688139 · Cited by 1,258
Self-citationInterleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment
Willerford, D. M., Chen, J., Ferry, J. A., Davidson, L., Ma, A. I., & Alt, F. W. (1995) · Immunity · doi:10.1016/1074-7613(95)90180-9 · Cited by 1,079
Requirement for Transcription Factor IRF-1 in NO Synthase Induction in Macrophages
Kamijo, R., Harada, H., Matsuyama, T., Bosland, M. C., Gerecitano, J. F., Shapiro, D., Le, J., Koh, S. I., Kimura, T., Green, S. J., et al. (1994) · Science · doi:10.1126/science.7510419 · Cited by 843
Self-citationTanaka, N., Ishihara, M., Kitagawa, M., Harada, H., Kimura, T., Matsuyama, T., Lamphier, M. S., Aizawa, S., Mak, T. W., & Taniguchi, T. (1994) · Cell · doi:10.1016/0092-8674(94)90132-5 · Cited by 491
Self-citationPip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator.
Eisenbeis, C. F., Singh, H., & Storb, U. (1995) · Genes & Development · doi:10.1101/gad.9.11.1377 · Cited by 447
An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes
Tamura, T., Ishihara, M., Lamphier, M. S., Tanaka, N., Oishi, I., Aizawa, S., Matsuyama, T., Mak, T. W., Taki, S., & Taniguchi, T. (1995) · Nature · doi:10.1038/376596a0 · Cited by 431
Self-citationBetz, A. G., Milstein, C., González‐Fernández, Á., Pannell, R., Larson, T., & Neuberger, M. S. (1994) · Cell · doi:10.1016/0092-8674(94)90316-6 · Cited by 379
An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes
石原, 正. (1997) · Cited by 366
Transitional B cells are the target of negative selection in the B cell compartment.
Carsetti, R., Köhler, G., & Lamers, M. C. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.6.2129 · Cited by 358
Interferon-Induced Antiviral Actions and Their Regulation
Sen, G. C., & Ransohoff, R. M. (1993) · Advances in virus research · doi:10.1016/s0065-3527(08)60083-4 · Cited by 334
Flagged first, then by citations
Research works printed but not linked: 4
- Lamphier M., Taniguchi T., Immunologist 2, 167 (1994);
- Vaughan P. S., et al., ibid. 377, 362 (1995);
- Schmits R., et al., ibid., p. 1415.
- Healthy 5- to 7-week-old mice were used for all experiments. Mice were maintained according to the guidelines of the Canadian Council of Animal Care. H.-W.M. is a recipient of a grant from the Deutsche Forschungsgemeinschaft. The authors thank M. Bachmann G. Boehmelt G. Duncan D. Ferrick C. Furlonger D. Kägi F. Kiefer L. Marengere C. Paige J. Penninger M. Saunders R. Schmits D. Siderovski D. Speiser S. Yoshinaga and P. Waterhouse for providing reagents and for helpful comments.
Cited by
Sorted by citations
Items 401–500 of 583
Deng, Y., Liu, K., Qiu, Q.-X., Tang, Z.-Y., Que, R.-M., Li, D.-K., Gu, X., Zhou, G., Wu, Y.-F., Zhou, L., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1126348 · Cited by 17
Prognostic Impact of MUM1/IRF4 Expression in Burkitt Lymphoma (BL)
Satou, A., Asano, N., Kato, S. X., Elsayed, A. A., Nakamura, N., Miyoshi, H., Ohshima, K., & Nakamura, S. (2017) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000804 · Cited by 17
Irf4 Expression in Thymic Epithelium Is Critical for Thymic Regulatory T Cell Homeostasis
Haljasorg, U., Dooley, J., Laan, M., Kisand, K. E., Bichele, R., Liston, A., & Peterson, P. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601698 · Cited by 17
Hatfield, S. D., Daniels, K. A., O’Donnell, C. L., Waggoner, S. N., & Welsh, R. M. (2018) · Virology · doi:10.1016/j.virol.2018.04.012 · Cited by 17
Azuaje, F. J. (2002) · IEEE International Symposium on Bio-Informatics and Biomedical Engineering (BIBE) · doi:10.1109/bibe.2000.889609 · Cited by 17
1α,25-dihydroxyvitamin D3 inhibits anti-CD40 plus IL-4-mediated IgE production in vitro
Heine, G., Anton, K., Henz, B. M., & Worm, M. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200212)32:12 · Cited by 124
Vav Proteins Regulate the Plasma Cell Program and Secretory Ig Production
Stephenson, L. M., Miletic, A. V., Kloeppel, T., Kusin, S. G., & Swat, W. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8620 · Cited by 17
Irf4 is a positional and functional candidate gene for the control of serum IgM levels in the mouse
Côrte‐Real, J., Rodo, J., Almeida, P., García, J. F., Coutinho, A., Demengeot, J., & Penha‐Gonçalves, C. (2008) · Genes and Immunity · doi:10.1038/gene.2008.73 · Cited by 16
Pather, S., Mohamed, Z., McLeod, H., & Pillay, K. (2013) · Pathology & Oncology Research · doi:10.1007/s12253-013-9632-2 · Cited by 16
Guo, Z., Xu, P., Ge, S., Zhang, C., Zheng, X., Xu, J., Liu, Z., Li, B., & Ge, S. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3087 · Cited by 16
Lotz, C., Mutallib, S. A., Oehlrich, N., Liewer, U., Ferreira, E. A., Moos, M., Hundemer, M., Schneider, S., Strand, S., Huber, C., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.1301 · Cited by 16
Identification of novel Stat6 regulated proteins in IL‐4‐treated mouse lymphocytes
Tuomela, S., Rautajoki, K. J., Moulder, R., Nyman, T. A., & Lahesmaa, R. (2009) · PROTEOMICS · doi:10.1002/pmic.200800161 · Cited by 16
Modulation and function of caspase pathways in B lymphocytes
Graves, J. D., Craxton, A., & Clark, E. A. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.0110.x · Cited by 16
Aloe-Emodin Ameliorates Diabetic Nephropathy by Targeting Interferon Regulatory Factor 4
Lü, L., & Li, Y. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/2421624 · Cited by 15
IRF4 drives clonal evolution and lineage choice in a zebrafish model of T-cell lymphoma
Amanda, S., Tan, T. K., Ong, J. Z. L., Theardy, M. S., Wong, R. W. J., Huang, X. Z., Ali, M. Z., Li, Y., Gong, Z., Inagaki, H., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30053-9 · Cited by 17
Trezise, S., Kong, I. Y., Hawkins, E. D., Herold, M. J., Willis, S. N., & Nutt, S. L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1089243 · Cited by 15
Luo, H., & Tian, M. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.02.016 · Cited by 15
Downregulation of IRF4 induces lytic reactivation of KSHV in primary effusion lymphoma cells
Forero, A., McCormick, K. D., Jenkins, F. J., & Sarkar, S. N. (2014) · Virology · doi:10.1016/j.virol.2014.04.020 · Cited by 14
Ribeiro, A., Dobosz, E., Krill, M., Köhler, P., Wadowska, M., Steiger, S., Schmaderer, C., Kozieł, J., & Lech, M. (2022) · Cells · doi:10.3390/cells11030397 · Cited by 15
PRC2 mediated KLF2 down regulation: a therapeutic and diagnostic axis during tumor progression
Taghehchian, N., Maharati, A., Akhlaghipour, I., Zangouei, A. S., & Moghbeli, M. (2023) · Cancer Cell International · doi:10.1186/s12935-023-03086-3 · Cited by 15
Schmidt, C., Harberts, A., Reimers, D., Bertram, T., Voß, L. C., Schmid, J., Lory, N. C., Spohn, M., Koch‐Nolte, F., Huber, S., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1182502 · Cited by 14
Self-citationRoles of IRF4 in various immune cells in systemic lupus erythematosus
Xiao, Z. X., Liang, R., Olsen, N. J., & Zheng, S. G. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112077 · Cited by 14
Blimp1: Driving Terminal Differentiation to a T
Xin, A., Nutt, S. L., Belz, G. T., & Kallies, A. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-5632-3_8 · Cited by 14
Chromosomal and genetic abnormalities in myeloma.
Ho, P. (2002) · Clinical & Laboratory Haematology · doi:10.1046/j.1365-2257.2002.00456.x · Cited by 6
IRF4 Couples Anabolic Metabolism to Th1 Cell Fate Determination
Kratchmarov, R., Nish, S. A., Lin, W.-H. W., Adams, W. C. T., Chen, Y., Yen, B., Rothman, N. J., Klein, U., & Reiner, S. L. (2017) · ImmunoHorizons · doi:10.4049/immunohorizons.1700012 · Cited by 14
He, X., Li, B., Yang, S., Lü, N., Zhang, X., Zou, S., Li, Y., Song, Y.-W., Zheng, S., Dong, M., et al. (2012) · 癌症:英文版 · doi:10.5732/cjc.011.10420 · Cited by 14
McKercher, S. R., Lombardo, C. R., Bobkov, A. A., Jia, X., & Assa‐Munt, N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0136910100 · Cited by 14
Sasaki, K., Terker, A. S., Tang, J., Cao, S., Arroyo, J. P., Niu, A., Wang, S., Fan, X., Zhang, Y., Bennett, S. R., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.150723 · Cited by 13
Transcriptomes of an Array of Chicken Ovary, Intestinal, and Immune Cells and Tissues
Overbey, E. G., Ng, T. T., Catini, P., Griggs, L., Stewart, P., Tkalčić, S., Hawkins, R. D., & Drechsler, Y. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.664424 · Cited by 12
Getting to the root of the problem: the causes of relapse in multiple myeloma
Chung, K. C., & Tiedemann, R. E. (2014) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2014.868776 · Cited by 12
Swaying the advantage: multifaceted functions of inflammasomes in adaptive immunity
Zouali, M. (2024) · FEBS Journal · doi:10.1111/febs.17204 · Cited by 12
Multi-tissue transcriptomic aging atlas reveals predictive aging biomarkers in the killifish
Costa, E. K., Chen, J., Guldner, I. H., Mboning, L., Schmahl, N., Tsenter, A., Nagvekar, R., Wu, M.-R., Losada, P. M., Bouchard, L.-S., et al. (2026) · Nature Aging · doi:10.1038/s43587-026-01074-6 · Cited by 18
Interferon regulatory factor-4 activates IL-2 and IL-4 promoters in cooperation with c-Rel
Shindo, H., Yasui, K., Yamamoto, K., Honma, K., Yui, K., Kohno, T., Ma, Y., Chua, K. J., Kubo, Y., Aihara, H., et al. (2011) · Cytokine · doi:10.1016/j.cyto.2011.08.014 · Cited by 12
Self-citationQiao, Y., Zhou, Y., Wu, C. H., Zhai, K., Han, X., Chen, J., Tian, X., Chang, J., Lu, Z., Zhang, B., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt082 · Cited by 12
Targeting plasma cells: are we any closer to a panacea for diseases of antibody‐secreting cells?
Low, M. S. Y., Infantino, S., Grigoriadis, G., & Tarlinton, D. M. (2016) · Immunological Reviews · doi:10.1111/imr.12388 · Cited by 13
Gupta, D. D., Paul, C., Samel, N., Bieringer, M., Staudenraus, D., Marini, F., Raifer, H., Menke, L., Hansal, L., Camara, B., et al. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-01005-z · Cited by 12
Boldison, J., Hopkinson, J. R., Davies, J. E., Pearson, J. A., Leete, P., Richardson, S. J., Morgan, N. G., & Wong, F. S. (2022) · Diabetologia · doi:10.1007/s00125-022-05839-7 · Cited by 12
Akazawa, S., Kobayashi, M., Kuriya, G., Horie, I., Yu, L., Yamasaki, H., Okita, M., Nagayama, Y., Matsuyama, T., Akbari, M., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3724-3 · Cited by 12
Self-citationBrown, M. C., Beasley, G. M., McKay, Z. P., Yang, Y., Desjardins, A., Randazzo, D. M., Landi, D. B., Ashley, D. M., Bigner, D. D., Nair, S. K., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-006463 · Cited by 11
Germline copy number variation associated with Mendelian inheritance of CLL in two families
Brown, J. R., Hanna, M., Tesar, B. M., Pochet, N. L. M. M., Vartanov, A. R., Fernandes, S. M., Werner, L. L., Ash, M., Roden, C., MacConaill, L. E., et al. (2012) · Leukemia · doi:10.1038/leu.2012.33 · Cited by 11
Lineage- and Stage-Specific Oncogenicity of IRF4
Amanda, S., Tan, T. K., Iida, S., & Sanda, T. (2022) · Experimental Hematology · doi:10.1016/j.exphem.2022.07.300 · Cited by 11
Wöhner, M., Pinter, T., Bönelt, P., Hagelkrüys, A., Kostanova‐Poliakova, D., Stadlmann, J., Konieczny, S. F., Fischer, M., Jaritz, M., & Busslinger, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.859598 · Cited by 11
BRAD4 plays a critical role in germinal center response by regulating Bcl-6 and NF-κB activation
Gao, F., Yang, Y., Wang, Z., Gao, X., & Zheng, B. Q. (2015) · Cellular Immunology · doi:10.1016/j.cellimm.2015.01.010 · Cited by 11
Zuo, J., Ge, H., Zhu, G., Matthias, P., & Sun, J. L. (2007) · Journal of Autoimmunity · doi:10.1016/j.jaut.2007.05.001 · Cited by 11
IRF4 promotes Epstein–Barr virus activation in Burkitt’s lymphoma cells
Gao, Y., Wang, L., Lei, Z., Li, J., Forrest, J. C., & Liang, X. (2019) · Journal of General Virology · doi:10.1099/jgv.0.001249 · Cited by 11
Metabolic Regulation of T Cell Immunity
Vignali, P., Barbi, J. J., & Pan, F. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-94-024-1170-6_2 · Cited by 10
Yasui, K., Izumida, M., Nakagawa, T., Kubo, Y., Hayashi, H., Ito, T., Ikeda, H., & Matsuyama, T. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.04.159 · Cited by 10
Self-citationKang, M., Lee, H., Choi, J. K., Yu, C., & Egwuagu, C. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052775 · Cited by 9
Miyakoda, M., Honma, K., Kimura, D., Akbari, M., Kimura, K., Matsuyama, T., & Yui, K. (2018) · European Journal of Immunology · doi:10.1002/eji.201747120 · Cited by 10
Self-citationIRF4 as an Oncogenic Biomarker for Hematological Malignancies
Ning, S. (2013) · Journal of Oncobiomarkers · doi:10.13188/2325-2340.1000003 · Cited by 10
Hall, B. M., Hall, R. M., Tran, G. T., Robinson, C. M., Wilcox, P. L., Rakesh, P., Wang, C., Sharland, A. F., Verma, N. D., & Hodgkinson, S. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.714838 · Cited by 11
Cai, M., & Chen, N. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.817069 · Cited by 10
Verma, N. D., Robinson, C. M., Carter, N. M., Wilcox, P. L., Tran, G. T., Wang, C., Sharland, A. F., Nomura, M., Plain, K. M., Bishop, G. A., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02397 · Cited by 10
Calame, K. L. (2001) · Nature · doi:10.1038/35085679 · Cited by 10
ACCOMMODATION AND THE REVERSIBILITY OF BIOLOGICAL SYSTEMS1
Holzknecht, Z. E., & Platt, J. L. (2001) · Transplantation · doi:10.1097/00007890-200103150-00002 · Cited by 10
Repression of DNA Repair Mechanisms in IRF-4-Expressing and HTLV-I-Infected T Lymphocytes
Mamane, Y., Loignon, M., Palmer, J., Hernandez, E., Césaire, R., Alaoui‐Jamali, M. A., & Hiscott, J. B. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.43 · Cited by 10
Transcriptional repression of type I IFN genes
Lopez, S., & Navarro, S. (1998) · Biochimie · doi:10.1016/s0300-9084(99)80022-4 · Cited by 10
IRF4 expression by NK precursors predetermines exhaustion of NK cells during tumor metastasis
Zhang, X., Yin, Z., Wu, J., Xiao, X., Zou, D., Wang, G., Fu, J., Lan, P., Minze, L. J., Li, X. C., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02176-w · Cited by 9
Toda, T., Kitabatake, M., Igarashi, H., & Sakaguchi, N. (2009) · European Journal of Immunology · doi:10.1002/eji.200838644 · Cited by 9
Shih, T. L., De, S., & Barnes, B. J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01652 · Cited by 9
Buchele, V., Konein, P., Vogler, T., Kunert, T., Enderle, K., Khan, H., Büttner-Herold, M. J., Lehmann, C. H. K., Amon, L., Wirtz, S. J., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.590893 · Cited by 9
Chronic Lymphocytic Leukaemia: A Review of the Immuno-architecture
Rosati, S., & Kluin, P. M. (2005) · Springer eBooks · doi:10.1007/3-540-29933-5_6 · Cited by 9
Tintelnot, J., Ufer, F., Engler, J. B., Winkler, H., Lücke, K., Mittrücker, H., & Friese, M. A. (2019) · European Journal of Immunology · doi:10.1002/eji.201847797 · Cited by 7
Self-citationFöh, B., Buhre, J. S., Sina, C., & Ehlers, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1004644 · Cited by 7
Murdoch, A. M., Patir, A., Seymen, F., & Vieira, A. R. (2009) · Journal of Oral Science · doi:10.2334/josnusd.51.521 · Cited by 9
Holic, L. (2024) · Medical Oncology · doi:10.1007/s12032-024-02385-7 · Cited by 7
Budzyńska, P. M., Niemelä, M., Sarapulov, A. V., Kyläniemi, M. K., Nera, K. ‐., Junttila, S., Laiho, A., Mattila, P. K., Alinikula, J., & Lassila, O. (2015) · Scandinavian Journal of Immunology · doi:10.1111/sji.12343 · Cited by 7
Role of IRF4-Mediated Inflammation: Implication in Neurodegenerative Diseases
Liu, F. (2017) · Neurology & Neurotherapy Open Access Journal · doi:10.23880/nnoaj-16000107 · Cited by 5
Lai, C. F., Wang, T., Yeh, M.-I., & Chen, T.-Y. (2020) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2020.08.033 · Cited by 7
Song, J., Ke, B., Tu, W., & Fang, X. (2023) · Renal Failure · doi:10.1080/0886022x.2023.2259228 · Cited by 7
Host T Cell Dedifferentiation Effects Drive HIV-1 Latency Stability
Dalecki, A. G., Greer, B. D., Duverger, A. E., Strange, E. L., Carlin, E., Wagner, F., Shi, B., Lowman, K. E., Perez, M. D., Tidwell, C., et al. (2022) · Journal of Virology · doi:10.1128/jvi.01974-21 · Cited by 7
Immunohistochemical expression of Mum-1, Oct-2 and Bcl-6 in systemic anaplastic large cell lymphomas
Sağlam, A., & Üner, A. (2011) · Tumori Journal · doi:10.1177/030089161109700516 · Cited by 7
Transcriptional Control of B Cell Activation
Corcoran, L. M. (2005) · Springer eBooks · doi:10.1007/3-540-26363-2_6 · Cited by 7
Comprehensive CRISPR-Cas9 screen identifies factors which are important for plasmablast development
Pinter, T., Fischer, M., Schäfer, M., Fellner, M., Jude, J., Zuber, J. A., Busslinger, M., & Wöhner, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.979606 · Cited by 6
B Cell–Intrinsic IRF4 Haploinsufficiency Impairs Affinity Maturation
Cook, S. L., Sievert, E. P., & Sciammas, R. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100747 · Cited by 6
Transcriptional Reprogramming during T Helper Cell Differentiation
Aune, T. M. (2001) · Immunologic Research · doi:10.1385/ir:23:2-3:193 · Cited by 6
Kurts, C., Carbone, F., Krummel, M. F., Koch, K. M., MILLER, J. F. A. P., & Heath, W. R. (2000) · Nature · doi:10.1038/35030185 · Cited by 6
Overview of Germinal Center Function and Structure in Normal and Genetically Engineered Mice
Tsiagbe, V. K., & Thorbecke, G. J. (1998) · Springer eBooks · doi:10.1007/978-3-662-13141-1_1 · Cited by 6
Murphy, M. K., McCullen, M. V. D., Deffenbaugh, J. L., Chen, A. Y., Pai, J. A., Dániel, B., Yousif, A., Raju, S., Hsiung, S., Wang, Z., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.09.008 · Cited by 8
Calderón, L., Schäfer, M., Rončević, M., Rauschmeier, R., Jaritz, M., Schwickert, T. A., Sun, Q., Pauli, A., Zuber, J. A., & Busslinger, M. (2026) · The Journal of Experimental Medicine · doi:10.1084/jem.20250594 · Cited by 6
Inflammasome functional activities in B lymphocytes
Hsu, M. L., Jhuang, K. F., & Zouali, M. (2024) · Immunologic Research · doi:10.1007/s12026-024-09490-9 · Cited by 5
Shi, W., Man, K., Smyth, G. K., Nutt, S. L., & Kallies, A. (2014) · Genomics Data · doi:10.1016/j.gdata.2014.10.019 · Cited by 5
Programmed T cell differentiation: Implications for transplantation
Crepeau, R. L., & Ford, M. L. (2020) · Cellular Immunology · doi:10.1016/j.cellimm.2020.104099 · Cited by 5
Nishiya, N., Yamamoto, K., Imaizumi, Y., Kohno, T., & Matsuyama, T. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.05.001 · Cited by 5
Self-citationInsights into the transcriptional regulation of CD22 in B cell chronic lymphocytic leukemia
Enkhbayar, B., Lu, S., Tsai, H.-Y., Liang, S., Wu, S., Lin, K., & Angata, T. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108386 · Cited by 4
Schmidt, J., Tafalla, C., Martin, D. L., & Lorenzen, N. (2025) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2025.110984 · Cited by 4
Zhang, L., Tie, X., Che, F., Wang, G., Ge, Y., Li, B., & Yang, Y. (2023) · Molecular Cytogenetics · doi:10.1186/s13039-023-00640-6 · Cited by 5
Tabata, R., Yasumizu, R., Tabata, C., & Kojima, M. (2013) · Journal of the Japan Society of the Reticuloendothelial System · doi:10.3960/jslrt.53.141 · Cited by 4
Zkscan3 gene is a potential negative regulator of plasma cell differentiation
Li, Z., Wen, C., Li, J., Meng, H., Ji, C., Han, Z., An, G., & Yang, L. (2019) · European Journal of Inflammation · doi:10.1177/2058739219850008 · Cited by 4
IRF4−/−Vh11 mice: a novel mouse model of CLL
Zhong, Y., & Byrd, J. C. (2013) · Blood · doi:10.1182/blood-2013-08-521120 · Cited by 4
Liu, S.-S., Ye, D., Lou, J., Fan, Z., & Ye, D. (2013) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-013-1279-6 · Cited by 4
Signaling Molecules Affecting Immune Response
Hertzog, P. J., Fenner, J. E., & Mansell, A. S. (2005) · Elsevier eBooks · doi:10.1016/b978-012455900-4/50267-1 · Cited by 4
In vivo Screen Identifies Zdhhc2 as a Critical Regulator of Germinal Center B Cell Differentiation
Zhao, R., Zhang, H., Zhang, Y., Li, D., Huang, C., & Li, F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01025 · Cited by 4
Voß, L. C., Schmidt, C., Harberts, A., Spohn, M., Bradtke, P., Borchers, A., Fertig, S., Schmid, J., Koch‐Nolte, F., Krebs, C. F., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1604888 · Cited by 3
Self-citationMonogenic disorders of the IRF transcription factors
Stojcic, M. P., Yousefi, P., Biggs, C. M., & Turvey, S. E. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20250939 · Cited by 4
Forster, P. M., Preußer, A., Yano, H., Deshpande, D., Zhang, W., Kowalczyk, A., Velleman, L., Dubik, M., Uddin, J., Emanuel, E., et al. (2026) · The Journal of Experimental Medicine · doi:10.1084/jem.20250781 · Cited by 3
Self-citationChen, D., Wang, Z., Cao, S., Lu, J., Liu, C., Yang, L., Du, X., Wang, H., & Li, Y. (2022) · Aquaculture Reports · doi:10.1016/j.aqrep.2022.101456 · Cited by 3
Ramani, M. V., Singh, R. K., Shrivastva, S., Ribeyron, L., Gupta, S. K., & Roy, A. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107578 · Cited by 3
Decoding transcriptional regulation via a human gene expression predictor
Wang, Y., Zhang, Y., Ning, Y., Li, B., Gong, J., Mei, Y., Bao, J., & Ma, S. (2023) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2023.01.006 · Cited by 3
Interferon regulatory factor 4 plays a pivotal role in the development of aGVHD-associated colitis
Frueh, J. T., Campe, J., Sunaga, D. Y., Verheyden, N. A., Ghimire, S., Meedt, E., Haslinger, D., Harenkamp, S., Staudenraus, D., Sauer, S., et al. (2023) · OncoImmunology · doi:10.1080/2162402x.2023.2296712 · Cited by 3
Metadata
- Authors
- Mittrücker, H.-W., Matsuyama, T., Grossman, A., Kündig, T. M., Potter, J., Shahinian, A., Wakeham, A., Patterson, B., Ohashi, P. S., & Mak, T. W.
- Affiliations
- University of Toronto (CA)
- Nagasaki University (JP)
- B. Patterson, Department of Oncologic Pathology, Ontario Cancer Institute, 610 University Avenue, Toronto, Ontario, M5G 2C1, Canada.
- Venue
- Science
- Published
- 1997-01-24
- Volume
- 275
- Issue
- 5299
- Pages
- 540-543
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2022687427
- Cited by
- 583
- References
- 21
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 12 · 2023: 20 · 2022: 23 · 2021: 23 · 2020: 17 · 2019: 15 · 2018: 16 · 2017: 20 · 2016: 15 · 2015: 18 · 2014: 25 · 2013: 32 · 2012: 20
- FWCI
- 8.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- IRF4, transcription factors, B cells, T cells, lymphocyte homeostasis, lymphadenopathy, antibody deficiency, antibody response, cytotoxic T lymphocytes, antitumor immunity
- MeSH terms
- Lymphadenopathy, Interferon Regulatory Factor-4, Animals, Antibody Formation, B-Lymphocytes, Cell Differentiation, Cells, Cultured, Homeostasis, Mice, Inbred BALB C, T-Lymphocytes, Cytotoxic, Transcription, Genetic, Mice, SCID, Mice, Knockout, Cell Proliferation, Interferon Regulatory Factors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review